The levels of HGF are increased in serum and in tumor tissues in colon cancer patients, particularly in patients with lymph node and liver metastasis [14], and are associated with poor survival of stage II and stage III colon cancer patients [15]. The gene discussed is HGF; the disease is malignant colon neoplasm.